Ney Carter Borges: Circadian Disruption and Melatonin Deficiency as Cardiovascular Risk Factors
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared on LinkedIn about a recent article by Jarosław Nuszkiewicz et al, adding:
“Circadian Rhythm Disruption and Cardiovascular Risk: The Role of Melatonin
Circadian rhythms are endogenous 24-hour cycles that regulate key cardiovascular functions, including blood pressure, heart rate, vascular tone, and metabolic homeostasis.
These rhythms are orchestrated by the suprachiasmatic nucleus (SCN), which synchronizes peripheral clocks through neuroendocrine signaling, particularly via melatonin secretion.
Melatonin, produced by the pineal gland during darkness with peak levels between 2:00 and 4:00 AM, acts as a central modulator of circadian alignment and cardiovascular physiology.
Disruption of circadian rhythms – caused by factors such as artificial light at night, shift work, irregular sleep patterns, and mistimed feeding – leads to circadian misalignment.
This condition promotes autonomic imbalance characterized by increased sympathetic activity and reduced parasympathetic tone, alongside heightened oxidative stress and systemic inflammation.
These mechanisms contribute directly to endothelial dysfunction, impaired vascular reactivity, and loss of normal nocturnal blood pressure dipping.
Melatonin exerts cardioprotective effects through antioxidant, anti-inflammatory, and autonomic regulatory pathways.
It enhances nitric oxide bioavailability, reduces reactive oxygen species, improves heart rate variability, and lowers blood pressure.
Consequently, circadian disruption combined with reduced melatonin signaling is associated with increased risk of hypertension, atherosclerosis, and overall cardiovascular disease.”
Title: Circadian Rhythm Disruptions and Cardiovascular Disease Risk: The Special Role of Melatonin
Authors: Jarosław Nuszkiewicz, Wojciech Rzepka, Julia Markiel, Marta Porzych, Alina Woźniak, Karolina Szewczyk-Golec
Read the Full Article on Current Issues in Molecular Biology (CIMB)

Other posts featuring Ney Carter Borges on Hemostasis Today.
-
Jun 29, 2026, 06:48Christina Pohlman: Anticoagulants and Bone Health – APS Awareness Month Day 23
-
Jun 29, 2026, 06:33Andreas Calatzis: Can Fibrinolysis Sensitivity Be Claimed Without a Reference Standard
-
Jun 29, 2026, 06:25Aliaa Albadri: When a Hair Wash Leads to a Stroke Workup
-
Jun 29, 2026, 06:22Tehreen Parveen: Historical Milestone in Drug Discovery – The Discovery of Aspirin
-
Jun 29, 2026, 06:16Muhammad Sufyan: Deep Vein Thrombosis – Recognizing the Warning Signs
-
Jun 29, 2026, 05:33Janak Sadhu: Uniting for The Stroke-Free Mehsana Initiative
-
Jun 29, 2026, 05:20Deepti Sachan: A Global Exchange Shaping the Future of Transfusion Medicine at ISBT 2026
-
Jun 29, 2026, 04:50Scott Cameron: ACC/AHA Guidance on Acute Pulmonary Embolism Management
-
Jun 29, 2026, 03:10Aryabhatta Sadhu: ABO and Rh Incompatibility In Stem Cell Transplantation